{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:53:09Z","timestamp":1788187989810,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Current guidelines recommend excisional\/complete biopsy for melanoma diagnosis, owing to high rates of residual disease found at wide local excision (WLE) after partial biopsy techniques. We sought to determine any survival disadvantage associated with the presence of residual invasive melanoma in the WLE after diagnosis with a partial biopsy technique.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY DESIGN:<\/jats:title>\n            <jats:p>Data were examined from Multicenter Selective Lymphadenectomy Trials I and II (MSLT-I and -II), 2 large melanoma trials. Patients diagnosed with excisional\/complete biopsy were excluded. Clinicopathologic characteristics, melanoma-specific survival (MSS), distant disease-free survival (DDFS), and disease-free survival (DFS) of those with residual invasive melanoma in the definitive WLE and those with no residual melanoma were compared. Matched pairing was used to reduce variability between groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>From 1994 through 2014, 3,939 patients were enrolled in these trials and 874 (22%) were diagnosed using partial biopsy techniques. Of these, 399 (46%) had residual tumor in the WLE. Only 6 patients had residual tumor in their WLE resulting in T-upstaging of their tumor. Match-pairing formed two cohorts (1:1) of patients with and without residual invasive tumor after WLE. A total of 514 patients were paired; 288 (56%) males, 148 (28.8%) aged 60 or older, 192 (37.4%) with truncal melanomas, 214 (41.6%) had Breslow thickness 2 mm or greater, and 376 (73.2%) had positive sentinel nodes. Kaplan-Meier analysis showed no statistical difference in 10-year MSS (73.6% \u00b1 3.3% vs 73.9% \u00b1 3.7%, p = 0.891), DDFS (68.7% \u00b1 3.4% vs 65.3% \u00b1 4.0%, p = 0.548), or DFS (59.6% \u00b1 3.7% vs 59.4% \u00b1 3.9%, p = 0.783).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Survival in patients with primary melanoma does not appear to be worse in patients who undergo a partial biopsy technique and are later found to have residual invasive tumor in the WLE specimen.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/xcs.0000000000000263","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T13:43:48Z","timestamp":1655300628000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Does Residual Invasive Disease in Wide Local Excision after Diagnosis with Partial Biopsy Technique Influence Survival in Melanoma? Matched-Pair Analysis of Multicenter Selective Lymphadenectomy Trial I and II"],"prefix":"10.1097","volume":"235","author":[{"given":"Judi Anne B","family":"Ramiscal","sequence":"first","affiliation":[{"name":"From Saint John\u2019s Cancer Institute at Providence Saint John\u2019s Health Center, Santa Monica, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L","family":"Stern","sequence":"additional","affiliation":[{"name":"From Saint John\u2019s Cancer Institute at Providence Saint John\u2019s Health Center, Santa Monica, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana K","family":"Wilson","sequence":"additional","affiliation":[{"name":"From Saint John\u2019s Cancer Institute at Providence Saint John\u2019s Health Center, Santa Monica, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D","family":"Lorimer","sequence":"additional","affiliation":[{"name":"From Saint John\u2019s Cancer Institute at Providence Saint John\u2019s Health Center, Santa Monica, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel A","family":"Lee","sequence":"additional","affiliation":[{"name":"From Saint John\u2019s Cancer Institute at Providence Saint John\u2019s Health Center, Santa Monica, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie R","family":"Goldfarb","sequence":"additional","affiliation":[{"name":"From Saint John\u2019s Cancer Institute at Providence Saint John\u2019s Health Center, Santa Monica, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leland J","family":"Foshag","sequence":"additional","affiliation":[{"name":"From Saint John\u2019s Cancer Institute at Providence Saint John\u2019s Health Center, Santa Monica, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevan D","family":"Fischer","sequence":"additional","affiliation":[{"name":"From Saint John\u2019s Cancer Institute at Providence Saint John\u2019s Health Center, Santa Monica, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"R3-20250821","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R4-20250821","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: Implications for melanoma treatment and care.","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"R6-20250821","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice guideline update.","volume":"36","author":"Wong","year":"2018","journal-title":"J Clin Oncol"},{"key":"R8-20250821","first-page":"196493","article-title":"Accuracy of diagnostic biopsy for cutaneous melanoma: Implications for surgical oncologists.","volume":"2013","author":"Hieken","year":"2013","journal-title":"Int J Surg Oncol"},{"key":"R9-20250821","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archdermatol.2010.14","article-title":"The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: Experience of an Australian tertiary referral service.","volume":"146","author":"Ng","year":"2010","journal-title":"Arch Dermatol"},{"key":"R10-20250821","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5694\/mja2.50289","article-title":"The increasing use of shave biopsy for diagnosing invasive melanoma in Australia.","volume":"211","author":"de Menezes","year":"2019","journal-title":"Med J Aust"},{"key":"R11-20250821","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/ajd.13227","article-title":"Think before you shave: Factors influencing choice of biopsy technique for invasive melanoma and effect on definitive management.","volume":"61","author":"de Menezes","year":"2020","journal-title":"Australas J Dermatol"},{"key":"R12-20250821","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jamcollsurg.2010.12.021","article-title":"Shave biopsy is a safe and accurate method for the initial evaluation of melanoma.","volume":"212","author":"Zager","year":"2011","journal-title":"J Am Coll Surg"},{"key":"R13-20250821","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.amjsurg.2013.01.023","article-title":"Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.","volume":"205","author":"Mills","year":"2013","journal-title":"Am J Surg"},{"key":"R14-20250821","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.amjsurg.2011.06.037","article-title":"The impact of biopsy technique on upstaging, residual disease, and outcome in cutaneous melanoma.","volume":"202","author":"Egnatios","year":"2011","journal-title":"Am J Surg"},{"key":"R15-20250821","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1245\/s10434-006-9302-7","article-title":"Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.","volume":"14","author":"Molenkamp","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R16-20250821","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0194599817740568","article-title":"Impact of biopsy modality on the management of cutaneous melanoma of the head and neck.","volume":"158","author":"Namin","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R17-20250821","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","article-title":"Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial.","volume":"242","author":"Morton","year":"2005","journal-title":"Ann Surg"},{"key":"R18-20250821","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma.","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"R19-20250821","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"30","author":"Michielin","year":"2019","journal-title":"Ann Oncol"},{"key":"R20-20250821","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1245\/s10434-021-09866-3","article-title":"Impact of shave biopsy on diagnosis and management of cutaneous melanoma: A systematic review and meta-analysis.","volume":"28","author":"Ahmadi","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R21-20250821","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-0560.2003.000002.x","article-title":"Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: Rate of tumor regression in excisional specimens.","volume":"30","author":"Swetter","year":"2003","journal-title":"J Cutan Pathol"},{"key":"R22-20250821","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","article-title":"Immunotherapy of melanoma: Facts and hopes.","volume":"25","author":"Weiss","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R23-20250821","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1200\/JCO.2007.14.6423","article-title":"Next generation of immunotherapy for melanoma.","volume":"26","author":"Kirkwood","year":"2008","journal-title":"J Clin Oncol"},{"key":"R24-20250821","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1067\/mjd.2002.123488","article-title":"Incisional biopsy and melanoma prognosis.","volume":"46","author":"Bong","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R25-20250821","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/000313480907500503","article-title":"Does shave biopsy accurately predict the final breslow depth of primary cutaneous melanoma?","volume":"75","author":"Moore","year":"2009","journal-title":"Am Surg"},{"key":"R26-20250821","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jamcollsurg.2017.05.013","article-title":"Impact of time between diagnosis and SLNB on outcomes in cutaneous melanoma.","volume":"225","author":"Nelson","year":"2017","journal-title":"J Am Coll Surg"},{"key":"R27-20250821","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.ejso.2016.05.012","article-title":"The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.","volume":"42","author":"Oude Ophuis","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"R28-20250821","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaad.2015.08.065","article-title":"Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.","volume":"74","author":"Bolshinsky","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R29-20250821","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ejso.2014.03.002","article-title":"Residual melanoma after an excisional biopsy is an independent prognostic factor for local recurrence and overall survival.","volume":"40","author":"Hocevar","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"R30-20250821","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1111\/jdv.16555","article-title":"Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: A rate of growth model.","volume":"34","author":"Tejera-Vaquerizo","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R31-20250821","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1111\/jdv.16874","article-title":"Delayed melanoma diagnosis in the COVID-19 era: Increased Breslow thickness in primary melanomas seen after the COVID-19 lockdown.","volume":"34","author":"Ricci","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R32-20250821","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/CMR.0000000000000717","article-title":"Impact of COVID-19 on melanoma diagnosis.","volume":"31","author":"Weston","year":"2021","journal-title":"Melanoma Res"},{"key":"R33-20250821","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archderm.142.12.1551","article-title":"Rate of growth in melanomas: Characteristics and associations of rapidly growing melanomas.","volume":"142","author":"Liu","year":"2006","journal-title":"Arch Dermatol"},{"key":"R34-20250821","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/CMR.0000000000000526","article-title":"Impact of initial stage on metastatic melanoma survival.","volume":"29","author":"Wilson","year":"2019","journal-title":"Melanoma Res"},{"key":"R35-20250821","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14740\/wjon1349","article-title":"Cutaneous malignant melanoma: A review of early diagnosis and management.","volume":"12","author":"Naik","year":"2021","journal-title":"World J Oncol"},{"key":"R36-20250821","first-page":"183","article-title":"Factors of delay in the diagnosis of melanoma.","volume":"13","author":"Betti","year":"2003","journal-title":"Eur J Dermatol"},{"key":"R37-20250821","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00403-021-02224-z","article-title":"A systematic review and synthesis of qualitative and quantitative studies evaluating provider, patient, and health care system-related barriers to diagnostic skin cancer examinations.","volume":"314","author":"Najmi","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"R38-20250821","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/mmt-2016-0022","article-title":"Skin cancer screening: Recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.","volume":"4","author":"Johnson","year":"2017","journal-title":"Melanoma Manag"}],"container-title":["Journal of the American College of Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T22:00:21Z","timestamp":1755813621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/xcs.0000000000000263","relation":{},"ISSN":["1072-7515"],"issn-type":[{"value":"1072-7515","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,5]]}}}